Bill > A05852

This bill requires manufacturers of kratom products in New York to include a specific warning label on their packaging starting January 1, 2026. The warning must be in at least 12-point type and a contrasting color, clearly stating that the product has not been approved by the FDA and listing potential side effects including nausea, agitation, hallucinations, breathing difficulties, liver damage, and potential death. The bill also prohibits kratom manufacturers from advertising or labeling their products as "all natural," which is defined as a product containing no artificial ingredients or added colors and minimally processed. Kratom, derived from a Southeast Asian tree, is an herbal supplement that will now be subject to these labeling requirements. Manufacturers who violate these regulations will face civil penalties, with a first violation resulting in a fine of up to $500 and subsequent violations incurring fines of up to $1,000. The law will go into effect one year after its passage, giving manufacturers time to adjust their packaging and marketing practices.

Business and Industry, Housing and Urban Affairs

https://www.nysenate.gov/legislation/bills/2025/A5852